PlainRecalls
FDA Drug Critical Class I Terminated

1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.

Reported: April 23, 2014 Initiated: September 16, 2013 #D-1234-2014

Product Description

1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.

Reason for Recall

Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.

Details

Recalling Firm
Hospira, Inc.
Units Affected
374,500 vials
Distribution
Nationwide
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.. Recalled by Hospira, Inc.. Units affected: 374,500 vials.
Why was this product recalled?
Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 23, 2014. Severity: Critical. Recall number: D-1234-2014.